References
- Kong W , LaceyS, MelenhorstJ, FraiettaJ. Biomarkers in chimeric antigen receptor T-cell therapy. Biomark. Med.12 (5), 415–418 (2018).
- Altmetric . Altmetric Explorer. (2018). www.altmetric.com
- Nixon M , BalkoJ. Biomarkers for assessing the effectiveness of immunotherapy in breast cancer. Biomark. Med.12 (2), 97–100 (2018).
- Deng M . A peripheral blood transcriptome biomarker test to diagnose functional recovery potential in advanced heart failure. Biomark. Med.12 (6), 619–635 (2018).
- Castello L , SalmiL, ZanottiIet al. The increase in copeptin levels in mild head trauma does not predict the severity and the outcome of brain damage. Biomark. Med.12 (6), 555–563 (2018).
- Jagarlamudi K , ShawM. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker. Biomark. Med.12 (9), 1035–1048 (2018).
- Seddighi S , VarmaV, ThambisettyM. α2-macroglobulin in Alzheimer’s disease: new roles for an old chaperone. Biomark. Med.12 (4), 311–314 (2018).
- Venneri A , Jahn-CartaC, De MarcoM, QuarantaD, MarraC. Diagnostic and prognostic role of semantic processing in preclinical Alzheimer’s disease. Biomark. Med.12 (6), 637–651 (2018).
- Tarring A . Biomarkers in Medicine: foreword. Biomark. Med.12 (1), 1–3 (2018).
- Twitter . Biomarkers in Med Jnl (@fsgbmm). (2018). www.twitter.com/fsgbmm